Literature DB >> 23298205

Pathways of antigen processing.

Janice S Blum1, Pamela A Wearsch, Peter Cresswell.   

Abstract

T cell recognition of antigen-presenting cells depends on their expression of a spectrum of peptides bound to major histocompatibility complex class I (MHC-I) and class II (MHC-II) molecules. Conversion of antigens from pathogens or transformed cells into MHC-I- and MHC-II-bound peptides is critical for mounting protective T cell responses, and similar processing of self proteins is necessary to establish and maintain tolerance. Cells use a variety of mechanisms to acquire protein antigens, from translation in the cytosol to variations on the theme of endocytosis, and to degrade them once acquired. In this review, we highlight the aspects of MHC-I and MHC-II biosynthesis and assembly that have evolved to intersect these pathways and sample the peptides that are produced.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298205      PMCID: PMC4026165          DOI: 10.1146/annurev-immunol-032712-095910

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  229 in total

1.  Optimization of the MHC class I peptide cargo is dependent on tapasin.

Authors:  Anthony P Williams; Chen Au Peh; Anthony W Purcell; James McCluskey; Tim Elliott
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

2.  Phagosomes are competent organelles for antigen cross-presentation.

Authors:  Mathieu Houde; Sylvie Bertholet; Etienne Gagnon; Sylvain Brunet; Guillaume Goyette; Annie Laplante; Michael F Princiotta; Pierre Thibault; David Sacks; Michel Desjardins
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

3.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules.

Authors:  M S Anderson; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 4.  Immunodominance: a pivotal principle in host response to viral infections.

Authors:  Ali Akram; Robert D Inman
Journal:  Clin Immunol       Date:  2012-02-10       Impact factor: 3.969

Review 5.  MHC II and the endocytic pathway: regulation by invariant chain.

Authors:  O J B Landsverk; O Bakke; T F Gregers
Journal:  Scand J Immunol       Date:  2009-09       Impact factor: 3.487

6.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.

Authors:  P A Roche; M S Marks; P Cresswell
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

7.  Translocation of long peptides by transporters associated with antigen processing (TAP).

Authors:  J O Koopmann; M Post; J J Neefjes; G J Hämmerling; F Momburg
Journal:  Eur J Immunol       Date:  1996-08       Impact factor: 5.532

8.  A role for UDP-glucose glycoprotein glucosyltransferase in expression and quality control of MHC class I molecules.

Authors:  Wei Zhang; Pamela A Wearsch; Yajuan Zhu; Ralf M Leonhardt; Peter Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

9.  Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway.

Authors:  Jun Kunisawa; Nilabh Shastri
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

10.  MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation.

Authors:  Aude De Gassart; Voahirana Camosseto; Jacques Thibodeau; Maurizio Ceppi; Nadia Catalan; Philippe Pierre; Evelina Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

View more
  517 in total

Review 1.  Autophagy and autophagy-related proteins in the immune system.

Authors:  Shusaku T Shibutani; Tatsuya Saitoh; Heike Nowag; Christian Münz; Tamotsu Yoshimori
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

Review 2.  Perspectives on antigen presenting cells in zebrafish.

Authors:  Kanako L Lewis; Natasha Del Cid; David Traver
Journal:  Dev Comp Immunol       Date:  2014-03-29       Impact factor: 3.636

Review 3.  Single-cell mass cytometry for analysis of immune system functional states.

Authors:  Zach B Bjornson; Garry P Nolan; Wendy J Fantl
Journal:  Curr Opin Immunol       Date:  2013-08-31       Impact factor: 7.486

Review 4.  In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology.

Authors:  Chenkai Mao; Michael-Joseph Gorbet; Akansha Singh; Ashish Ranjan; Steven Fiering
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

Review 5.  T-Cell Receptor-Based Immunotherapy for Hematologic Malignancies.

Authors:  Melinda A Biernacki; Michelle Brault; Marie Bleakley
Journal:  Cancer J       Date:  2019 May/Jun       Impact factor: 3.360

6.  Polyphosphate is an extracellular signal that can facilitate bacterial survival in eukaryotic cells.

Authors:  Ramesh Rijal; Louis A Cadena; Morgan R Smith; Joseph F Carr; Richard H Gomer
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-02       Impact factor: 11.205

7.  Ezrin tunes the magnitude of humoral immunity.

Authors:  Debasis Pore; Neetha Parameswaran; Ken Matsui; Matthew B Stone; Ichiko Saotome; Andrea I McClatchey; Sarah L Veatch; Neetu Gupta
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 8.  Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum.

Authors:  Nilabh Shastri; Niranjana Nagarajan; Kristin C Lind; Takayuki Kanaseki
Journal:  Curr Opin Immunol       Date:  2013-12-11       Impact factor: 7.486

9.  Examining the Biosynthesis and Xenoantigenicity of Class II Swine Leukocyte Antigen Proteins.

Authors:  Joseph M Ladowski; Gregory R Martens; Luz M Reyes; Zheng-Yu Wang; Devin E Eckhoff; Vera Hauptfeld-Dolejsek; Matt Tector; A Joseph Tector
Journal:  J Immunol       Date:  2018-03-14       Impact factor: 5.422

Review 10.  Functions of heat shock proteins in pathways of the innate and adaptive immune system.

Authors:  Robert Julian Binder
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.